_ Hepatitis C Many Insurers Deny Coverage for Highly Effective Hep C Drugs By Jane Farrell article Drugs that can cure chronic hepatitis C infection in approximately 95 percent of patients first became available in the U.S. … Read More→
_ Hepatitis C Expanding Hepatitis C Testing to All Adults Is Cost-Effective and Improves Outcomes By Sondra Forsyth article According to a February 2018 study published online in Clinical Infectious Diseases, screening all adults for hepatitis C (HCV) is … Read More→
_ Hepatitis C New Hepatitis C Infections Have Tripled over The Past Five Years By Jane Farrell article EditorΓÇÖs Note: Hepatitis C is a potentially deadly viral infection, and the majority of deaths occur in people 55 and … Read More→
_ Hepatitis C Hepatitis C Treatments Give Patients More Options By Jane Farrell article Transformative advances in drug treatments approved by the U.S. Food and Drug Administration (FDA) are giving the 3.2 million Americans … Read More→
_ Hepatitis C Liver Transplants for Hep C: A Surprising Finding By Sondra Forsyth article An international team of researchers was surprised to find that in some hepatitis C patients who receive liver transplants, genes that target the hepatitis C virus (HCV) as part of the innate immune system actually enable the patients to tolerate a foreign organ without taking immunosuppressant medication. The study was published in July 2014 in Science Translational Medicine.